716 related articles for article (PubMed ID: 37505336)
1. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance.
Fakhri S; Moradi SZ; Faraji F; Farhadi T; Hesami O; Iranpanah A; Webber K; Bishayee A
Cancer Metastasis Rev; 2023 Sep; 42(3):959-1020. PubMed ID: 37505336
[TBL] [Abstract][Full Text] [Related]
2. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.
Sa P; Sahoo SK; Dilnawaz F
Curr Med Chem; 2023; 30(29):3335-3355. PubMed ID: 36154585
[TBL] [Abstract][Full Text] [Related]
3. TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity.
Panagi M; Voutouri C; Mpekris F; Papageorgis P; Martin MR; Martin JD; Demetriou P; Pierides C; Polydorou C; Stylianou A; Louca M; Koumas L; Costeas P; Kataoka K; Cabral H; Stylianopoulos T
Theranostics; 2020; 10(4):1910-1922. PubMed ID: 32042344
[TBL] [Abstract][Full Text] [Related]
4. Improving drug delivery to solid tumors: priming the tumor microenvironment.
Khawar IA; Kim JH; Kuh HJ
J Control Release; 2015 Mar; 201():78-89. PubMed ID: 25526702
[TBL] [Abstract][Full Text] [Related]
5. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.
Gao Q; Feng J; Liu W; Wen C; Wu Y; Liao Q; Zou L; Sui X; Xie T; Zhang J; Hu Y
Adv Drug Deliv Rev; 2022 Sep; 188():114445. PubMed ID: 35820601
[TBL] [Abstract][Full Text] [Related]
6. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery.
Zhang LY; Zhang JG; Yang X; Cai MH; Zhang CW; Hu ZM
Curr Top Med Chem; 2020; 20(30):2789-2800. PubMed ID: 33076809
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
8. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
[TBL] [Abstract][Full Text] [Related]
9. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
10. The tumor microenvironment: shaping cancer progression and treatment response.
Desai SA; Patel VP; Bhosle KP; Nagare SD; Thombare KC
J Chemother; 2024 Jan; ():1-30. PubMed ID: 38179655
[TBL] [Abstract][Full Text] [Related]
11. Anticancer nanomedicines harnessing tumor microenvironmental components.
Li Y; Chen Z; Gu L; Duan Z; Pan D; Xu Z; Gong Q; Li Y; Zhu H; Luo K
Expert Opin Drug Deliv; 2022 Apr; 19(4):337-354. PubMed ID: 35244503
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple-negative breast cancer.
Cao Y; Meng F; Cai T; Gao L; Lee J; Solomevich SO; Aharodnikau UE; Guo T; Lan M; Liu F; Li Q; Viktor T; Li D; Cai Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1950. PubMed ID: 38528388
[TBL] [Abstract][Full Text] [Related]
13. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
15. Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis.
Gu X; Gao Y; Wang P; Wang L; Peng H; He Y; Liu Y; Feng N
J Control Release; 2021 May; 333():374-390. PubMed ID: 33798666
[TBL] [Abstract][Full Text] [Related]
16. Wnt Signaling in the Tumor Microenvironment.
Ruan Y; Ogana H; Gang E; Kim HN; Kim YM
Adv Exp Med Biol; 2021; 1270():107-121. PubMed ID: 33123996
[TBL] [Abstract][Full Text] [Related]
17. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
18. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
19. Remodeling tumor microenvironment with nanomedicines.
Martin JD; Miyazaki T; Cabral H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1730. PubMed ID: 34124849
[TBL] [Abstract][Full Text] [Related]
20. Antibody-Functionalized Nanoformulations for Targeted Therapy of Colorectal Cancer: A Systematic Review.
Cepero A; Luque C; Cabeza L; Perazzoli G; Quiñonero F; Mesas C; Melguizo C; Prados J
Int J Nanomedicine; 2022; 17():5065-5080. PubMed ID: 36345508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
